February 23, 2017 / 6:51 AM / 5 months ago

BRIEF-Recipharm Q4 EBITDA 229 mln SEK

1 Min Read

Feb 23 (Reuters) - Recipharm AB

* Q4 net sales amounted to sek 1 333 million (863), an increase of 54%

* Recipharm ab (publ) says proposed share dividend is sek (1.50) per share

* Q4 ebitda increased by 108% and amounted to sek 229 million (110)

* Recipharm ab (publ) says we are well on track to reach our long-term financial targets and overall objectives Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below